~~SECURITIES~~UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

WASHINGTON, D.C. 20549

_________________

FORM 8-K

~~_________________~~CURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~CURRENT~~April ~~REPORT~~2, 2008Date of Report (Date of earliest event reported)

~~PURSUANT~~BODYTEL TOSCIENTIFIC INC.(Exact ~~SECTION~~name 13of ORregistrant ~~15(D)~~as OFspecified in its charter)

THE SECURITIES EXCHANGE ACT OF 1934

NEVADA	000-51633	98-0461698
(State or other jurisdiction of	(Commission File	(IRS Employer Identification No.)
incorporation)	Number)


One Independent Drive, Suite 1701, Jacksonville, FL		32202
(Address of principal executive offices)		(Zip Code)

~~Date~~904.305.8634Registrant's oftelephone ~~Report (Date of earliest event reported): September 4~~number, including ~~2007~~area code

~~BODYTEL~~N/A(Former ~~SCIENTIFIC~~name ~~INC.~~or former address, if changed since last report)

~~(Exact~~Check ~~Name~~the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of ~~Registrant~~the asregistrant ~~Specified~~under any inof ~~Its~~the ~~Charter)~~following provisions:

~~Nevada~~____ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

~~(State~~____ orSoliciting ~~Other~~material ~~Jurisdiction~~pursuant ofto ~~Incorporation~~Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

~~000~~____ Pre-~~51633 98~~commencement communications pursuant to Rule 14d-~~0461698~~2(b) under the Exchange Act (17 CFR 240.14d -2(b))

____ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -~~--------------------------- --------------------------------------~~4(c))

~~(Commission~~Item ~~File~~5.02 ~~Number) (IRS~~Departure ~~Employer~~Of ~~Identification~~Directors NoOr Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers.)

~~2470~~Effective ~~St.Rose~~April ~~Pkwy~~2, ~~Suite~~2008, ~~304~~BodyTel Scientific Inc. (the “Company”) appointed Paul Barry and Larry Rosenfeld to the Company’s Board of Directors.

~~-----------------------------------------------------------------~~Mr. Barry is an experienced corporate finance executive with substantial experience in private equity financings. Previously he was an executive in the Leveraged Finance group of HSBC with responsibility for structuring and syndicating private equity transactions in the United Kingdom and continental Europe. Prior to that he was at Morgan Stanley in London advising on M&A transactions, corporate restructurings and IPOs, principally for private equity clients. Mr. Barry has a degree in electrical engineering from University College in Cork, Ireland

~~(Address~~Larry Rosenfeld is the CEO of ~~Principal~~VitalStream Health, a spin-out company of the Cleveland Clinic. Mr. Rosenfeld was the founder and from 1984-1998, Chairman and CEO of Concentra Corporation, a Massachusetts-based software company that he led from its inception in 1984, through its IPO on Nasdaq in 1995 and until its sale to Oracle in December 1998. Concentra was a leading provider of knowledge-based engineering and sales force automation software. Major customers included Boeing, Airbus, GE, United Technologies, GM, Ford, Sumitomo, Nokia and many other global companies. From 1998 until the present, Mr. Rosenfeld has served on the boards of a number of US and International corporations such as Ansaldo Signal, a $400 million railroad signal company and Benco Dental, the largest private dental supply company in the US. He also has advised a number growing companies and has succeeded in leading a number of M&A transactions. In addition, he has served as Trustee and Executive ~~Offices) (Zip~~Director ~~Code)~~of Team Adventure Education Foundation and navigated one of the fastest sailboats around the world in The Race and set sailing world records across the Pacific. Mr. Rosenfeld earned a BS in mathematics in 1976 from Hampshire College, Amherst, MA.

~~-----------------------------------------------------------------~~Item 9.01 Financial Statements And Exhibits.

(~~Registrant's Telephone Number, Including Area Code~~d) Exhibits

------------------------------------------------------------------

Exhibit	Description of Exhibit
Number
99.1	Press Release dated April 7, 2008 announcing appointment of Paul Barry and Larry Rosenfeld

~~(Former Name or Former Address, if Changed Since Last Report)~~SIGNATURE

~~Check~~Pursuant to the ~~appropriate~~requirements ~~box~~of ~~below~~the ifSecurities Exchange Act of 1934, the ~~Form~~registrant ~~8-K~~has ~~filing~~duly iscaused ~~intended~~this report to be signed on its behalf by the undersigned hereunto duly authorized.

simultaneously satisfy the filing obligation of the registrant under any of the

	BODYTEL SCIENTIFIC INC.
Date: April 7, 2008
	By:	/s/ Stefan Schraps
		STEFAN SCHRAPS, PRESIDENT

following provisions.

[_] Written communications pursuant to Rule 425 under the Securities Act

(17 CFR240.14d-2(b))

[_] Soliciting material pursuant to Rule 14a-12 under Exchange Act

(17 CFR240.14a-12)

[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange

Act (17 CFR240.14d-2(b))

[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange

Act (17 CFR240.13e-4(c))

SECTION 8 – OTHER EVENTS

Item 8.01. Other Events

On September 4, 2007, the Registrant issued a press release announcing that Michael Berrendorf has joined BodyTel as the Company’s Sales Director for the EMEA (Europe, Middle East and Africa) region, a copy of the Press Release is attached as Exhibit 99.1.

The foregoing description is qualified in its entirety by reference to the Registrant’s Press Release dated September 4, 2007, a copy of which is attached hereto as Exhibit 99.1.

SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS

Item 9.01. Financial Statements and Exhibits

(a) Financial Statements of business acquired. Not applicable

(b) Pro forma financial information. Not applicable

Exhibit 99.1

Press Release of Registrant dated September 4, 2007

SIGNATURES

Pursuant to the requirements of the Securities Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

BodyTel Scientific Inc.

By: /s/ Stefan Schraps

------------------------------

President and CEO

Date: September 18, 2007

Endnotes

Filing Compare · BODYTEL SCIENTIFIC INC.